Enwei Pharmaceutical Co., Ltd. (SHE:301331)

Enwei Pharmaceutical Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 22, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	3,693	2,307	2,911	2,789	-	-
Market Cap Growth	1.60%	-20.75%	4.40%	-	-	-
Enterprise Value	3,368	2,014	2,403	2,225	-	-
Last Close Price	36.54	22.94	27.32	25.21	-	-
PE Ratio	80.92	61.53	33.73	41.13	-	-
PS Ratio	4.48	2.84	3.71	4.03	-	-
PB Ratio	3.43	2.18	2.64	2.42	-	-
P/TBV Ratio	4.36	2.80	3.41	2.76	-	-
P/FCF Ratio	72.05	80.43	-	71.88	-	-
P/OCF Ratio	37.87	29.24	34.66	44.72	-	-
EV/Sales Ratio	4.08	2.48	3.06	3.22	-	-
EV/EBITDA Ratio	35.65	23.18	20.87	22.42	-	-
EV/EBIT Ratio	73.53	47.96	29.89	32.57	-	-
EV/FCF Ratio	65.70	70.19	-	57.35	-	-
Debt / Equity Ratio	0.18	0.19	0.00	-	-	-
Debt / EBITDA Ratio	2.09	2.25	0.01	-	-	-
Debt / FCF Ratio	3.86	6.90	-	-	-	-
Asset Turnover	-	0.57	0.57	0.61	0.79	0.79
Inventory Turnover	-	3.63	3.63	3.23	3.17	3.65
Quick Ratio	3.75	3.42	3.16	3.64	1.38	1.29
Current Ratio	4.43	3.99	3.75	4.21	2.08	1.75
Return on Equity (ROE)	4.16%	3.47%	7.65%	7.55%	16.56%	19.64%
Return on Assets (ROA)	-	1.85%	3.66%	3.75%	7.25%	8.12%
Return on Capital (ROIC)	2.41%	2.22%	4.45%	4.76%	10.14%	11.99%
Return on Capital Employed (ROCE)	3.60%	3.30%	7.10%	5.80%	14.90%	16.90%
Earnings Yield	1.23%	1.63%	2.96%	2.43%	-	-
FCF Yield	1.39%	1.24%	-1.72%	1.39%	-	-
Dividend Yield	0.49%	0.78%	1.98%	6.35%	-	-
Payout Ratio	125.52%	151.90%	130.02%	-	45.22%	1.52%
Buyback Yield / Dilution	1.82%	1.82%	-21.93%	-8.34%	-6.51%	6.12%
Total Shareholder Return	2.32%	2.61%	-19.96%	-2.00%	-6.51%	6.12%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.